Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway*
暂无分享,去创建一个
K. Gaus | J. Stow | J. Kay | L. Kritharides | J. Burnett | M. Traini | W. Jessup | M. Van Eck | W. Le Goff | Sabine H. Wimmer-Kleikamp | M. Kockx | Dongni Lily Guo | Carles Rentero
[1] K. Wasan,et al. Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma. , 2008, International journal of pharmaceutics.
[2] L. Kritharides,et al. Regulation of endogenous apolipoprotein E secretion by macrophages. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[3] L. Rohrer,et al. Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI , 2008, Journal of Molecular Medicine.
[4] I. Gelissen,et al. Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters A1 and G1 , 2008, Circulation research.
[5] K. Gaus,et al. Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A– and Calcium-Dependent Pathway Along the Microtubule Network , 2007, Circulation research.
[6] Vadim Zinchuk,et al. Quantitative Colocalization Analysis of Multicolor Confocal Immunofluorescence Microscopy Images: Pushing Pixels to Explore Biological Phenomena , 2007, Acta histochemica et cytochemica.
[7] M. Linton,et al. A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[8] A. Vaughan,et al. ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease , 2006, Circulation research.
[9] R. Mahley,et al. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] F. Sacks,et al. Apolipoprotein-mediated pathways of lipid antigen presentation , 2005, Nature.
[11] Dipak P. Ramji,et al. The key role of apolipoprotein E in atherosclerosis , 2005, Journal of Molecular Medicine.
[12] Jonathan D. Smith,et al. Cyclosporin A Traps ABCA1 at the Plasma Membrane and Inhibits ABCA1-Mediated Lipid Efflux to Apolipoprotein A-I , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[13] Z. Huang,et al. Oleic Acid Modulates the Post-translational Glycosylation of Macrophage ApoE to Increase Its Secretion* , 2004, Journal of Biological Chemistry.
[14] R. Dean,et al. Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux* , 2004, Journal of Biological Chemistry.
[15] Sheng-tian Li,et al. Inhibition of excitatory neuronal cell death by cell‐permeable calcineurin autoinhibitory peptide , 2003, Journal of neurochemistry.
[16] L. Miller. Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] R. Traber,et al. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter. , 2002, Journal of medicinal chemistry.
[18] R. S. Kiss,et al. Trypsin-sensitive and Lipid-containing Sites of the Macrophage Extracellular Matrix Bind Apolipoprotein A-I and Participate in ABCA1-dependent Cholesterol Efflux* , 2002, The Journal of Biological Chemistry.
[19] D. Gu,et al. Regulation of Macrophage ApoE Expression and Processing by Extracellular Matrix* , 2002, The Journal of Biological Chemistry.
[20] R. Dean,et al. A kinetic model to evaluate cholesterol efflux from THP-1 macrophages to apolipoprotein A-1. , 2001, Biochemistry.
[21] A. von Eckardstein,et al. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte‐derived macrophages , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] N. Vaziri,et al. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. , 2000, The Journal of pharmacology and experimental therapeutics.
[23] T. Mazzone,et al. Endogenously expressed apolipoprotein E has different effects on cell lipid metabolism as compared to exogenous apolipoprotein E carried on triglyceride-rich particles. , 2000, Biochemistry.
[24] T. Mazzone,et al. Transport and Processing of Endogenously Synthesized ApoE on the Macrophage Cell Surface* , 2000, The Journal of Biological Chemistry.
[25] A. Monks,et al. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. , 1999, Biochemical pharmacology.
[26] T. Mazzone,et al. Degradation of Macrophage ApoE in a Nonlysosomal Compartment , 1997, The Journal of Biological Chemistry.
[27] L Timmermann,et al. The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.
[28] C. Florén,et al. Cyclosporine inhibits catabolism of low‐density lipoproteins in HepG2 cells by about 25% , 1996, Hepatology.
[29] S. Snyder,et al. Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux , 1995, Cell.
[30] L. Dory,et al. Lysosomal degradation and sorting of apolipoprotein E in macrophages. , 1995, Journal of lipid research.
[31] S. Fazio,et al. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.
[32] R. Dean,et al. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[33] R. Mahley,et al. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. , 1994, The Journal of biological chemistry.
[34] Stuart L. Schreiber,et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.
[35] F. Kuipers,et al. Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis. , 1991, The Biochemical journal.
[36] J. Taylor,et al. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.
[37] V. Zannis,et al. Intracellular modifications of human apolipoprotein E. , 1986, The Journal of biological chemistry.
[38] J. Breslow,et al. Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. , 1984, The Journal of biological chemistry.
[39] R. Mahley,et al. Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.
[40] R. Mahley,et al. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.